SARS-CoV-2, Flu A, Flu B & RSV Antibody Pairs

SARS-CoV-2, Flu A, Flu B & RSV Antibody Pairs for combo rapid antigen tests

A key focus for managing the COVID-19 pandemic during the flu season is diagnostic testing that can differentiate SARS-CoV-2 from other respiratory infections that have similar symptoms. Several immunoassays and molecular multiplex tests for SARS-CoV-2, Flu A, Flu B and RSV have been EUA approved by the FDA or received a CE mark. Rapid point-of-care lateral flow assays pose a significant benefit for clinicians as it allows them to differentially diagnose a patient with respiratory symptoms using a single swab, all within one appointment. A successful multiplex assay must demonstrate high specificity for each disease with no cross-reactivity. In addition, the sensitivity of the assay needs to meet the same limit of detection as a singleplex assay in order to be effective. This requires using monoclonal antibodies that have high affinity and specificity for their target molecule.

High Sensitivity MAb Pairs

Meridian Life Science has several high performing pairs for SARS-CoV-2, RSV, Flu A and Flu B which are ideal for use in a multiplex point-of-care assay.

Capture #9547

Detection #9548

Capture #C01769M

Detection #C01773M

* Pair detects new UK variant B.1.1.7

Capture #C65063M

Detection #C65065M

Capture #C01746M

Detection #C01747M

Capture #C01747M

Detection #C01744M

Capture #C01736M

Detection #C01731M

Capture #C01744M

Detection #C01897M

Capture #C01732M

Detection #C01731M

Ordering information: USA 5171 Wilfong Road Memphis, Tennessee 38134 Fax: +1 901-333-8223 Toll Free: +1 800 327 6299

Email: info@meridianlifescience.com Orders: orders@meridianlifescience.com www.MeridianLifeScience.com

Connect with us:

ISO 13485 Certified

01/21

Page 1

meridianlifescience.com

Powered by